Cargando…
Polo样激酶1抑制剂在奥希替尼耐药的非小细胞肺癌细胞中的作用
OBJECTIVE: To investigate the effects of PLK1 inhibitors on osimertinib-resistant non-small cell lung carcinoma (NSCLC) cells and the anti-tumor effect combined with osimertinib. METHODS: An osimertinib resistant NCI-H1975 cell line was induced by exposure to gradually increasing drug concentrations...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
《浙江大学学报》编辑部
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630054/ https://www.ncbi.nlm.nih.gov/pubmed/37899396 http://dx.doi.org/10.3724/zdxbyxb-2023-0305 |